{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-25-000120","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2025-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.541336+00:00","generated_at":"2026-05-17T08:18:27.130980+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"LivaNova appoints Donald Zurbay to Board and Audit Committee","bullets":["Donald Zurbay appointed to LivaNova Board and Audit & Compliance Committee effective September 4, 2025.","Zurbay most recently President & CEO of Patterson Companies (Oct 2022-May 2025); previously CFO at Patterson and St. Jude Medical.","Compensation: $70k annual retainer, $15k audit committee fee, $185k annual restricted stock award, prorated until 2026 AGM.","No material transactions or arrangements between Zurbay and LivaNova per Item 404(a) review."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-25-000120","json":"https://secwatch.observer/filing/0001639691-25-000120.json","markdown":"https://secwatch.observer/filing/0001639691-25-000120.md","text":"https://secwatch.observer/filing/0001639691-25-000120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969125000120/0001639691-25-000120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969125000120/livn-20250903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:18:27.130980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}